the swedish ticlopidine multicentre study ( stims ) was a double-blind placebo-controlled trial designed to determine whether ticlopidine , a platelet antiaggregatory agent , reduces the incidence of myocardial infarction , stroke and transitory ischaemic attacks in patients with intermittent claudication .
C0040207
ticlopidine
C0038454
stroke